Product-specific advice (steroid nasal sprays) [Design Issues]

posted by Mikalai  – Belarus, 2018-10-16 15:42 (2813 d 14:48 ago) – Posting: # 19451
Views: 5,041

Dear friends,
Are there any explicit recommendations or guidelines from EMA about how to establish bio-equivalence for nasal sprays with steroids? More specifically, how can we avoid a therapeutic equivalence study, European approach? Are there any recommendations on Morphologically-Directed Raman Spectroscopy (MDRS) as a substitute for a therapeutic equivalence study? Any references will be appreciated.

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
300 visitors (0 registered, 300 guests [including 23 identified bots]).
Forum time: 06:30 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5